Research Article
Antimutagenicity of Methanolic Extracts from Anemopsis californica in Relation to Their Antioxidant Activity
Table 1
Mutagenic activity of SME and LME.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SME and LME: stem and leaf methanolic extracts, respectively. SR: spontaneous revertants. Positive controls: TA98: picrolonic acid (PA) (50 g/Petri dish) without S9, , His+ revertants; (2AA) 2-aminoanthracene (10 g/Petri dish) with S9, ; TA100: methyl-N′-nitro-N-nitrosoguanidine (MNNG), (10 g/Petri dish) without S9, 5,881.17 ± 861.49, (CF) cyclophosphamide (500 g/Petri dish) with S9, ; TA102: mitomycin C (2 ng/Petri dish) without, 3,401.67 ± 703.37, 2AA (10 g/Petri dish) 1,264.83 ± 77.38. S9 rat liver homogenate induced with aroclor 1254. |